ERCC1 polymorphisms in patients with advanced bladder cancer treated with platinum-based chemotherapy

被引：0
|
作者：
Bamias, A.
Nikitas, N.
Karadimou, A.
Gika, D.
Karavasilis, V.
Briasoulis, E. C.
Chrisofos, M.
Murray, S.
Pectasides, D. G.
Dimopoulos, M. A.
机构：
[1] Alexandra Peripheral Gen Hosp, Athens, Greece
[2] Univ Athens, Athens, Greece
[3] Univ Thessaloniki, GR-54006 Thessaloniki, Greece
[4] Hellen Cooperat Oncol Grp Data Off, Athens, Greece
[5] Metropolitan Hosp, Athens, Greece
[6] Univ Athens, Sch Med, Dept Therapeut, GR-11527 Athens, Greece
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e15066
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15066
引用
收藏
页数：1
相关论文
共 50 条
  • [1] ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy
    Grazia Palomba
    Francesco Atzori
    Mario Budroni
    MariaNeve Ombra
    Antonio Cossu
    MariaCristina Sini
    Valeria Pusceddu
    Bruno Massidda
    Barbara Frau
    Francesca Notari
    MariaTeresa Ionta
    Giuseppe Palmieri
    Journal of Translational Medicine, 12
  • [2] ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy
    Palomba, Grazia
    Atzori, Francesco
    Budroni, Mario
    Ombra, MariaNeve
    Cossu, Antonio
    Sini, MariaCristina
    Pusceddu, Valeria
    Massidda, Bruno
    Frau, Barbara
    Notari, Francesca
    Ionta, MariaTeresa
    Palmieri, Giuseppe
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12 : 1 - 8
  • [3] ERCC1 expression in metastatic triple negative breast cancer patients treated with platinum-based chemotherapy
    El Baiomy, M.
    El Kashef, W.
    El Zafarany, M.
    BREAST, 2017, 32 : S92 - S92
  • [4] Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy
    Mo, Juanmei
    Luo, Min
    Cui, Jiandong
    Zhou, Shaozhang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (11): : 15065 - 15071
  • [5] Expression of ERCC1 protein in biopsy specimen predicts survival in advanced ovarian cancer patients treated with platinum-based chemotherapy
    Milovic-Kovacevic, M.
    Srdic-Rajic, T.
    Radulovic, S.
    Bjelogrlic, S.
    Gavrilovic, D.
    JOURNAL OF BUON, 2011, 16 (04): : 708 - 714
  • [6] ERCC1 expression predicts treatment response and survival in advanced uterine cervical cancer patients treated with platinum-based chemotherapy
    Baek, S. W.
    Choi, Y. S.
    Song, I. C.
    Yun, H. J.
    Jo, D. Y.
    Kim, S. Y.
    Lee, H. J.
    ANNALS OF ONCOLOGY, 2015, 26 : 81 - 82
  • [7] Low ERCC1 expression is associated with prolonged survival in patients with bladder cancer receiving platinum-based neoadjuvant chemotherapy
    Ozcan, Muhammet Fuat
    Dizdar, Omer
    Dincer, Nazmiye
    Balci, Serdar
    Guler, Gulnur
    Gok, Bahri
    Pektas, Gokhan
    Seker, Mehmet Metin
    Aksoy, Sercan
    Arslan, Cagatay
    Yalcin, Suayib
    Balbay, Mevlana Derya
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (08) : 1709 - 1715
  • [8] ERCC1 and ERCC2 Polymorphisms Predict the Efficacy and Toxicity of Platinum-Based Chemotherapy in Small Cell Lung Cancer
    Barba, Andres
    Lopez-Vilaro, Laura
    Ferre, Malena
    Majem, Margarita
    Martinez-Recio, Sergio
    Bell, Olga
    Arranz, Maria J.
    Salazar, Juliana
    Sullivan, Ivana
    PHARMACEUTICS, 2024, 16 (09)
  • [9] ERCC1 Codon 118 polymorphism is a useful prognostic marker in patients with pancreatic cancer treated with platinum-based chemotherapy
    Kamikozuru, H.
    Kuramochi, H.
    Hayashi, K.
    Uchida, K.
    Yamamoto, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] ERCC1 codon 118 polymorphism is a useful prognostic marker in patients with pancreatic cancer treated with platinum-based chemotherapy
    Kamikozuru, Hirotaka
    Kuramochi, Hidekazu
    Hayashi, Kazuhiko
    Nakajima, Go
    Yamamoto, Masakazu
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2008, 32 (05) : 1091 - 1096
12345